Clinical Trials
59 trialsHemi-Gland Cryoablation for Prostate Cancer at UCLA
Jonsson Comprehensive Cancer Center
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Blue Earth Therapeutics Ltd
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
Endocyte
P300
Pathos AI, Inc.
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Celcuity Inc
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
STRIKE-001
K36 Therapeutics, Inc.
A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer
Antev Ltd.
Biobank for African American Prostate Cancer Research in Florida
H. Lee Moffitt Cancer Center and Research Institute
Test Semiquantitative Prostate Specific Antigen (PSA)
Institut Curie
Health Gatherings - For Your Health After Cancer
University of Miami
Exploring the Potential of Robotic Telesurgery in Remote Settings
AdventHealth
IP7-PACIFIC
Imperial College London
PROter
Advanced Accelerator Applications
MAPROSTATE
Marmara University
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
Poseida Therapeutics, Inc.
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
UNICANCER
TEAM PC
Fundacion Oncosur
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
VA Greater Los Angeles Healthcare System
High Resolution Diffusion Weighted Imaging in Prostate
The First Affiliated Hospital with Nanjing Medical University
Clinical Investigation of the da Vinci Surgical System
Intuitive Surgical
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
Steba Biotech S.A.
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
Northwell Health
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer
Northwell Health
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Beth Israel Deaconess Medical Center
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Aragon Pharmaceuticals, Inc.
A Study of FT-7051 in Men With MCRPC
Novo Nordisk A/S
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Menoufia University
FuncProst
Oslo University Hospital
The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters
Hisar Intercontinental Hospital
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer
OHSU Knight Cancer Institute
PHRC2003
Institut Bergonié
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
British Columbia Cancer Agency
Micro-Ultrasound/Magnetic Resonance Imaging 001
University Health Network, Toronto
PROfind
Advanced Accelerator Applications
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
PSMA-PROSTAPET
Azienda Ospedaliero-Universitaria di Modena
COMO-GMC
University of Aarhus
Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer
NanOlogy, LLC
MR/TRUS Fusion Guided Prostate Biopsy
Icahn School of Medicine at Mount Sinai
PCM301
Steba Biotech S.A.
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
Rigshospitalet, Denmark
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Cedars-Sinai Medical Center
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
ESSA Pharmaceuticals
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Novartis
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Dendreon
Character Traits and Stress in Suspected Prostate Cancer
Helse Stavanger HF